AU4944500A - A method for optimizing immune activity in the treatment of auto-immune diseases and chronic immune conditions - Google Patents

A method for optimizing immune activity in the treatment of auto-immune diseases and chronic immune conditions

Info

Publication number
AU4944500A
AU4944500A AU49445/00A AU4944500A AU4944500A AU 4944500 A AU4944500 A AU 4944500A AU 49445/00 A AU49445/00 A AU 49445/00A AU 4944500 A AU4944500 A AU 4944500A AU 4944500 A AU4944500 A AU 4944500A
Authority
AU
Australia
Prior art keywords
immune
auto
treatment
optimizing
conditions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU49445/00A
Inventor
Robert H. Jacobs
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU4944500A publication Critical patent/AU4944500A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A61K31/6615—Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU49445/00A 1999-06-29 2000-06-13 A method for optimizing immune activity in the treatment of auto-immune diseases and chronic immune conditions Abandoned AU4944500A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US14143799P 1999-06-29 1999-06-29
US60/141437 1999-06-29
US17738700P 2000-01-24 2000-01-24
US60/177387 2000-01-24
PCT/IB2000/000791 WO2001000194A2 (en) 1999-06-29 2000-06-13 A method for optimizing immune activity in the treatment of auto-immune diseases and chronic immune conditions

Publications (1)

Publication Number Publication Date
AU4944500A true AU4944500A (en) 2001-01-31

Family

ID=26839119

Family Applications (1)

Application Number Title Priority Date Filing Date
AU49445/00A Abandoned AU4944500A (en) 1999-06-29 2000-06-13 A method for optimizing immune activity in the treatment of auto-immune diseases and chronic immune conditions

Country Status (2)

Country Link
AU (1) AU4944500A (en)
WO (1) WO2001000194A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006516633A (en) * 2003-01-29 2006-07-06 エクシトン−エクシマー ゲーエムベーハー Therapeutic compositions for treating HIV-1 and HIV-2
JP5138380B2 (en) * 2004-11-24 2013-02-06 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド Methods for increasing immune responses in animals
EP1792619A1 (en) 2005-11-28 2007-06-06 Laboratorios Maymo, S.A. Beta-sitosterol for treating porcine respiratory disease complex
SG184715A1 (en) * 2007-05-31 2012-10-30 Suntory Holdings Ltd Anti-fatigue agents and oral compositions containing andrographolide as active ingredient

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01149730A (en) * 1987-12-07 1989-06-12 Osaka Prefecture Retrovirus proliferation inhibitor
US5082833A (en) * 1988-06-30 1992-01-21 Shamsuddin Abulkalam M Reduction of cell proliferation and enhancement of nk-cell activity
JPH0215032A (en) * 1988-07-01 1990-01-18 Sanwa Kagaku Kenkyusho Co Ltd Remedy and preventive for liver disease and drink and favorite food having strong liver functionality
US5217959A (en) * 1990-09-06 1993-06-08 Robert Sabin Method of treating multiple sclerosis with phytic acid

Also Published As

Publication number Publication date
WO2001000194A2 (en) 2001-01-04
WO2001000194A3 (en) 2001-12-20

Similar Documents

Publication Publication Date Title
AU6375399A (en) Electromagnetic-field therapy method and device
AU7949400A (en) Mechanical heart valve and production method thereof
AU5788300A (en) Medical treatment method and kit
AU1227302A (en) System and method for optimizing drug therapy for the treatment of diseases
AU9028798A (en) Method of improving drug treatment
AU3494599A (en) Epitope-driven human antibody production and gene expression profiling
AU4508301A (en) Interactive systems and methods for supporting hemofiltration therapies
AU4171500A (en) Flupirtine in the treatment of fibromyalgia and related conditions
AUPQ155799A0 (en) Therapeutic methods and uses
AU4646500A (en) Shells for temporary and provisional crowns with an hourglass-shaped occlusal profile
AU7042796A (en) Pharmaceutical agents for the treatment of acute and chronic inflammatory diseases
IL146449A0 (en) Method and pharmaceutical preparations for reducing the activity of cells
AU3752200A (en) System and method for processing blood
AU2024101A (en) Artificial tooth and controller
AU2001292553A1 (en) Chronic illness treatment system and method
AU4944500A (en) A method for optimizing immune activity in the treatment of auto-immune diseases and chronic immune conditions
AU3393600A (en) Method for safely and effectively administering a drug by inhalation
EP1079335A4 (en) Bill processor and its controlling method
AU3833700A (en) Agents and methods for the control of fungal and bacterial diseases
AU2981400A (en) Modular system and method for processing transactions
AU3453300A (en) Processor and processing method
AU6416894A (en) A detection and quantitation method for therapeutic agents in blood
AU4725697A (en) Model mouse for human diseases
AU2352301A (en) Gene expression in corneal diseases
AU6886398A (en) Transgenic model and treatment for heart disease

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase